{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:30:32Z","timestamp":1760027432814},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are 2 rare but life-threatening diseases characterized by detachment of epidermis, bullous skin lesions, and mucous membrane erosions. Drugs are highly suspected to be the causative agents. We report a case of SJS\/TEN induced by oseltamivir, which is a very rare event.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 9-year-old girl with upper respiratory tract infections presented with generalized maculopapular rash the second day after taking oseltamivir.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The diagnosis of SJS\/TEN was made based on cytotoxic skin lesions and mucous membrane involvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>After discontinuing of the drug and combination therapy of corticosteroid and human immunoglobulin initiation, the lesions were improved. Human leukocyte antigen (HLA) gene sequencing was done.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The girl was followed-up for 1 year. The skin and mucous membranes symptoms were relieved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We report this case to attract attention to the rare but serious side effect of this antiviral drug.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000015553","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:02:59Z","timestamp":1557741779000},"page":"e15553","source":"Crossref","is-referenced-by-count":9,"title":["Oseltamivir induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis\u2014case report"],"prefix":"10.1097","volume":"98","author":[{"given":"Wei","family":"Zuo","sequence":"first","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing"},{"name":"Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education\u201d, Yantai University, Yantai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Wen","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Mei","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230915","article-title":"Current perspectives on Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","author":"Marianne","year":"2017","journal-title":"Clinic Rev AllergImmunol"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/etm.2015.2549","article-title":"Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"10","author":"Chantaphakul","year":"2015","journal-title":"Exp Ther Med"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4103\/0366-6999.204929","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 88 Chinese patients","volume":"130","author":"Wang","year":"2017","journal-title":"Chin Med J"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.burns.2016.01.014","article-title":"A decade of burn unit experience with Stevens-Johnson syndrome\/toxic epidermal necrolysis: clinical pathological diagnosis and risk factor awareness","volume":"42","author":"Lim","year":"2016","journal-title":"Burns"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.burns.2016.07.026","article-title":"Steven Johnson syndrome and toxic epidermal necrolysis in a burn unit: a 15-year experience","volume":"43","author":"McCullough","year":"2017","journal-title":"Burns"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12325-012-0050-8","article-title":"Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review","volume":"29","author":"Toovey","year":"2012","journal-title":"Adv Ther"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1136\/bmj.f4656","article-title":"Neuropsychiatric adverse effects of oseltamivir in the FDA adverse event reporting system, 1999\u20132012","volume":"347","author":"Hoffman","year":"2013","journal-title":"BMJ"},{"key":"R8-20230915","first-page":"e76","article-title":"Toxic epidermal necrolysis after treatment with oseltamivir. Case report","volume":"108","author":"Luna","year":"2010","journal-title":"Arch Argent Pediatr"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/FPC.0000000000000287","article-title":"HLA-A\u221731: 01 and HLA-B\u221715:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population","volume":"27","author":"Khor","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B\u22171502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","article-title":"Carbamazepine, HLA-B\u22171502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations","volume":"9","author":"Ferrell","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.phrs.2016.11.027","article-title":"Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS\/TEN are different from those found for the same AED-induced DRESS in the Spanish population","volume":"115","author":"Ramirez","year":"2017","journal-title":"Pharmacol Res"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1212\/WNL.0000000000004008","article-title":"HLA-A\u221724:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions","volume":"88","author":"Shi","year":"2017","journal-title":"Neurology"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/pgs.09.162","article-title":"Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"11","author":"Hung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1212\/WNL.0000000000003453","article-title":"Taiwan severe cutaneous adverse reaction consortium. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2013.04.013","article-title":"HLA-B\u221758:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population","volume":"71","author":"Niihara","year":"2013","journal-title":"J Dermatol Sci"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/tpj.2015.25","article-title":"HLA-B\u221759:01: a marker for Stevens-Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese","volume":"16","author":"Yang","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.10.54","article-title":"HLA-B\u22175901 is strongly associated with methazolamide induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Kim","year":"2010","journal-title":"Pharmacogenomics"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/jhg.2016.160","article-title":"Genome-wide association study using the ethnicity-specific Japonica array: identification of new susceptibility loci for cold medicine-related Stevens-Johnson syndrome with severe ocular complications","volume":"62","author":"Ueta","year":"2017","journal-title":"J Hum Genet"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit Care Med"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"R24-20230915","first-page":"5451","article-title":"Carbamazepine for acute and chronic pain in adults","volume":"2011","author":"Wiffen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/ijd.12423","article-title":"Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies","volume":"54","author":"Barron","year":"2015","journal-title":"Int J Dermatol"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","article-title":"A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres","volume":"40","author":"Mahar","year":"2014","journal-title":"Burns"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2217\/pgs.15.128","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction","volume":"16","author":"Rufini","year":"2015","journal-title":"Pharmacogenomics"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201905100-00068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:22:02Z","timestamp":1694820122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201905100-00068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":26,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000015553","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}